+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CSL Behring - logo

CSL Behring is a global leader in the plasma protein biotherapeutics industry. It specializes in bleeding disorder, fluid replacement, hereditary angioedema, immunoglobulin, pulmonary, and wound healing biotherapies. Its therapies are being used to treat coagulation disorders, primary immune deficiencies, neurological conditions, inherited respiratory diseases and a variety of others. The company was founded in 2000 and is based in King of Prussia, Pennsylvania.

From
From
Myocardial Infarction - Pipeline Insight, 2024 - Product Thumbnail Image

Myocardial Infarction - Pipeline Insight, 2024

  • Clinical Trials
  • July 2024
  • 180 Pages
  • Global
From
From
From
Disease Analysis: Hemophilia - Product Thumbnail Image

Disease Analysis: Hemophilia

  • Report
  • June 2021
  • 102 Pages
  • Global
From
From
From
Intravenous Immunoglobulin Global Market Report 2024 - Product Thumbnail Image

Intravenous Immunoglobulin Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Immunoglobulins Global Market Report 2024 - Product Thumbnail Image

Immunoglobulins Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Myositis - Pipeline Insight, 2024 - Product Thumbnail Image

Myositis - Pipeline Insight, 2024

  • Drug Pipelines
  • November 2024
  • 80 Pages
  • Global
From
From
From
Plasma Derived Therapy Market Report and Forecast 2024-2032 - Product Thumbnail Image

Plasma Derived Therapy Market Report and Forecast 2024-2032

  • Report
  • September 2023
  • 160 Pages
  • Global
From
Loading Indicator